Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Total Revenue of $1.64 billion for the year ending 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed an increase of +1.5% in Total Revenue from 2024 to 2025.
- This data is from INTEGRA LIFESCIENCES HOLDINGS CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $258.64 million | Q2 2017: $282.16 million | Q3 2017: $278.83 million | Q4 2017: $368.60 million | Q1 2018: $357.08 million | Q2 2018: $366.19 million | Q3 2018: $365.85 million | Q4 2018: $383.32 million | Q1 2019: $359.69 million | Q2 2019: $383.65 million | Q3 2019: $379.10 million | Q4 2019: $395.13 million | Q1 2020: $354.32 million | Q2 2020: $258.67 million | Q3 2020: $370.23 million | Q4 2020: $388.65 million | Q1 2021: $360.07 million | Q2 2021: $389.99 million | Q3 2021: $386.86 million | Q1 2022: $376.64 million | Q2 2022: $397.82 million | Q3 2022: $385.19 million | Q1 2023: $380.85 million | Q2 2023: $381.27 million | Q3 2023: $382.42 million | Q1 2024: $368.87 million | Q2 2024: $418.18 million | Q3 2024: $380.83 million | Q1 2025: $382.65 million | Q2 2025: $415.61 million | Q3 2025: $402.06 million.
- Over the full 10 years of available data (2016 to 2025), INTEGRA LIFESCIENCES HOLDINGS CORP's Total Revenue has grown by 64.8%.
- Historical annual values: Fiscal year 2025: $1.64 billion | Fiscal year 2024: $1.61 billion | Fiscal year 2023: $1.54 billion | Fiscal year 2022: $1.56 billion | Fiscal year 2021: $1.54 billion | Fiscal year 2020: $1.37 billion | Fiscal year 2019: $1.52 billion | Fiscal year 2018: $1.47 billion | Fiscal year 2017: $1.19 billion | Fiscal year 2016: $992.08 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: